Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
16 Results Found
AHA Comments to MedPAC on Rural Medicare Beneficiary Cost-sharing
February 28, 2025Michael Chernew, Ph.D.ChairmanMedicare Payment Advisory Commission425 I Street, NW, Suite 701Washington, D.C. 20001Dear Dr. Chernew:
AHA Urges Administration to Grant Exceptions for Tariffs for Medications and Medical Supplies
The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the provision of safe, effective care in America's hospitals, clinics, and other settings.
AHA Comments to CMS on Financial Assistance Program Navigators
AHA response to CMS's request for comment on how navigators and non-navigator assistance personnel working within hospitals and health systems may help consumers access financial assistance programs to help pay for health care services.
AHA to President Urging the Administration to Take Action to Address IV Solution Supply Shortage as a Result of Helene
AHA letter to President Biden urging the Administration to take action to address IV solution supply shortage as a result of hurricane Helene.
Comments on CMS’ Proposed Rule on Fraudulent Billing Activity within the Medicare Shared Savings Program
AHA's comments on CMS' proposed rule to mitigate the impact of significant, anomalous and highly suspect (SAHS) billing activity within the Medicare Shared Savings Program (MSSP) in calendar year (CY) 2023.
AHA Comments on the Proposed Change to Section 301 Tariffs for Goods Made in China – 90183100
June 28, 2024 The Honorable Katherine TaiU.S. Trade Representative600 17th Street NWWashington, DC 20508
AHRMM LUC Comments to the FDA’s Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices
The AHRMM LUC members submitted comments and recommendations to the FDA's Draft Guidance for Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices. They recommend that information related to all Class I Medical Devices be included in the GUDID without exception.
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)
Letter/Comment
On November 21, 2013, AHRMM submitted electronically